John D. Markman

4.5k total citations
61 papers, 1.6k citations indexed

About

John D. Markman is a scholar working on Pharmacology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, John D. Markman has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 23 papers in Physiology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in John D. Markman's work include Musculoskeletal pain and rehabilitation (32 papers), Pain Mechanisms and Treatments (23 papers) and Pain Management and Opioid Use (15 papers). John D. Markman is often cited by papers focused on Musculoskeletal pain and rehabilitation (32 papers), Pain Mechanisms and Treatments (23 papers) and Pain Management and Opioid Use (15 papers). John D. Markman collaborates with scholars based in United States, United Kingdom and Germany. John D. Markman's co-authors include Robert H. Dworkin, David N. Herrmann, Alec O'connor, Steven R. Schwid, Bruce Parsons, Alesia Sadosky, Markay Hopps, Jennifer S. Gewandter, Jack Mardekian and E. Jay Bienen and has published in prestigious journals such as Neurology, Pain and Spine.

In The Last Decade

John D. Markman

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Markman United States 22 522 482 434 346 221 61 1.6k
Massimo Allegri Italy 24 485 0.9× 305 0.6× 114 0.3× 99 0.3× 555 2.5× 92 1.8k
A. Baranowski United Kingdom 21 383 0.7× 361 0.7× 84 0.2× 109 0.3× 415 1.9× 58 1.8k
Jan Vollert Germany 25 1.1k 2.1× 514 1.1× 70 0.2× 525 1.5× 143 0.6× 93 1.9k
Joanne Muir United States 9 853 1.6× 330 0.7× 94 0.2× 383 1.1× 154 0.7× 11 1.4k
Buwei Yu China 23 333 0.6× 174 0.4× 161 0.4× 122 0.4× 302 1.4× 65 1.4k
Ann De Smedt Belgium 24 181 0.3× 348 0.7× 64 0.1× 195 0.6× 110 0.5× 82 1.6k
David Rog United Kingdom 16 209 0.4× 561 1.2× 572 1.3× 274 0.8× 36 0.2× 62 1.4k
Rioko Kimiko Sakata Brazil 20 270 0.5× 288 0.6× 132 0.3× 60 0.2× 617 2.8× 110 1.4k
Kori L. Brewer United States 21 423 0.8× 98 0.2× 293 0.7× 166 0.5× 120 0.5× 101 1.5k
Yi Feng China 22 392 0.8× 171 0.4× 171 0.4× 104 0.3× 558 2.5× 150 1.6k

Countries citing papers authored by John D. Markman

Since Specialization
Citations

This map shows the geographic impact of John D. Markman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Markman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Markman more than expected).

Fields of papers citing papers by John D. Markman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Markman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Markman. The network helps show where John D. Markman may publish in the future.

Co-authorship network of co-authors of John D. Markman

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Markman. A scholar is included among the top collaborators of John D. Markman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Markman. John D. Markman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markman, John D., et al.. (2024). Multidevice spinal cord stimulation trials: shared decision making in the era of multiple neuromodulation paradigms. Pain Management. 14(8). 413–420. 2 indexed citations
2.
Watt, Stephen, Ed Whalen, Leo Russo, et al.. (2022). Multimethod quantitative benefit‐risk assessment of treatments for moderate‐to‐severe osteoarthritis. British Journal of Clinical Pharmacology. 88(8). 3837–3846. 4 indexed citations
3.
Markman, John D., Thomas J. Schnitzer, Serge Perrot, et al.. (2022). Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial. Pain and Therapy. 11(4). 1267–1285. 4 indexed citations
4.
Koreckij, Theodore D., D. Scott Kreiner, Jad G. Khalil, et al.. (2021). Prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 24-Month treatment arm results. North American Spine Society Journal (NASSJ). 8. 100089–100089. 24 indexed citations
5.
McNicol, Ewan D, McKenzie Ferguson, Kathleen M. Bungay, et al.. (2020). Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for Pain. Journal of Pain. 22(2). 127–142. 12 indexed citations
6.
Markman, John D., Partap S. Khalsa, Salim M. Hayek, et al.. (2020). AAPT Diagnostic Criteria for Chronic Low Back Pain. Journal of Pain. 21(11-12). 1138–1148. 17 indexed citations
7.
Towner, James, et al.. (2018). Anatomical Study of Percutaneous Trigeminal Compressive Balloon Positioning on Merged 3-D Rotational X-Ray and Preprocedural Magnetic Resonance Imaging. Stereotactic and Functional Neurosurgery. 96(3). 182–189. 3 indexed citations
8.
9.
Gewandter, Jennifer S., Michael McDermott, Scott Evans, et al.. (2017). Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations. BMJ Open. 7(7). e017288–e017288. 21 indexed citations
10.
Smith, Shannon M., Jennifer S. Gewandter, John D. Markman, et al.. (2016). Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study. Journal of Pain. 17(11). 1198–1206. 10 indexed citations
11.
Markman, John D., et al.. (2015). Corticosteroids for Pain of Spinal Origin. Rheumatic Disease Clinics of North America. 42(1). 137–155. 9 indexed citations
12.
Webster, Lynn R. & John D. Markman. (2014). Medical Management of Chronic Low Back Pain: Efficacy and Outcomes. Neuromodulation Technology at the Neural Interface. 17. 18–23. 14 indexed citations
13.
Sadosky, Alesia, Jack Mardekian, Bruce Parsons, et al.. (2014). Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy. Journal of Diabetes and its Complications. 29(2). 212–217. 95 indexed citations
14.
Markman, John D., et al.. (2014). Screening for Neuropathic Characteristics in Failed Back Surgery Syndromes: Challenges for Guiding Treatment. Pain Medicine. 16(3). 520–530. 25 indexed citations
15.
Dworkin, Robert H., Dennis C. Turk, Ethan Basch, et al.. (2011). Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain. 152(8). 1705–1708. 25 indexed citations
16.
Markman, John D.. (2008). Not so fast : The reformulation of fentanyl and breakthrough chronic non-cancer pain. Pain. 136(3). 227–229. 16 indexed citations
17.
Markman, John D., et al.. (2008). Lumbar Spinal Stenosis in Older Adults: Current Understanding and Future Directions. Clinics in Geriatric Medicine. 24(2). 369–388. 36 indexed citations
18.
Simon, Lee S., Christopher J. Evans, Nathaniel P. Katz, et al.. (2007). Preliminary development of a responder index for chronic low back pain.. PubMed. 34(6). 1386–91. 29 indexed citations
19.
O'connor, Alec, Steven R. Schwid, David N. Herrmann, John D. Markman, & Robert H. Dworkin. (2007). Pain associated with multiple sclerosis: Systematic review and proposed classification. Pain. 137(1). 96–111. 355 indexed citations
20.
Ackers, Marta‐Louise, John D. Markman, Wallis E. DeWitt, et al.. (2000). An Outbreak ofYersinia enterocoliticaO:8 Infections Associated with Pasteurized Milk. The Journal of Infectious Diseases. 181(5). 1834–1837. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Allegri Breakdown of academic impact, for papers by A. Baranowski Breakdown of academic impact, for papers by Jan Vollert Breakdown of academic impact, for papers by Joanne Muir Breakdown of academic impact, for papers by Buwei Yu Breakdown of academic impact, for papers by Ann De Smedt Breakdown of academic impact, for papers by David Rog Breakdown of academic impact, for papers by Rioko Kimiko Sakata Breakdown of academic impact, for papers by Kori L. Brewer Breakdown of academic impact, for papers by Yi Feng
Rankless by CCL
2026